The other was performed by van Schaardenburg D et al. [17], who reported statistically significant increased mean levels of OPG and N-terminal type I procollagen pro-peptide in preclinical RA compared to controls. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.